Traumeel S

Phase 3Small molecule

SShaare Zedek Medical Center

Traumeel S is one of 75 small molecule programs targeting Mucositis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MucositisActive, not recruiting

Hallux ValgusActive, not recruiting

SprainActive, not recruiting

MucositisPreclinical

Active, not recruiting

Hallux ValgusPhase 3

Active, not recruiting

SprainPhase 3

Active, not recruiting

Competition

Competitive Landscape

63 competitors in Mucositis

#DrugCompanyPhaseTrials

Galzin

AAmerican Regent, Inc.

Approved

1 2

Ethyol

LLegacy Health System

Approved

—3

Dilaudid

RRhodes Pharmaceuticals, L.P.

Approved

—4

Neurontin

VViatris Specialty LLC

Phase 3

1 5

Duragesic

CCephalon

Phase 3

1 6

MS Contin

HHikma Pharmaceuticals LLC

Phase 3

1 7

Nubain

AAultman Health Foundation

Phase 3

1 8

Advil

KKenvue Brands

Phase 3

1 9

Diflucan

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 10

Aquasol E

NNational Eye Institute (NEI)

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Mucositis2 trials

A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis

Completed·UUniversity of Oklahoma·Phase 1·NCT00584597·14 enrolled

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Completed·CChildren's Oncology Group·N/A·NCT00080873·195 enrolled

Hallux valgus1 trial

TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial

Completed·SShaare Zedek Medical Center·Phase 3·NCT00279513

Sprain1 trial

TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain

Completed·BBiologische Heilmittel Heel GmbH·Phase 3·NCT01066520·449 enrolled

Fracture1 trial

TRAUMEEL for Pain After Fracture of Neck of Femur

Withdrawn·SShaare Zedek Medical Center·Phase 3·NCT00307905·224 enrolled

Hip Arthroplasty1 trial

TRAUMEEL for Pain After Total Knee/Hip Arthroplasty

Terminated·SShaare Zedek Medical Center·Phase 3·NCT00307853·224 enrolled

2 more indications

Tonsillectomy1 trial

Traumeel for Post-Tonsillectomy Pain

Unknown status·SShaare Zedek Medical Center·Phase 3·NCT00410332·20 enrolled

Dexamethasone1 trial

92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus

Unknown status·FFederal University of the Valleys of Jequitinhonha and Mucuri·N/A·NCT03567369·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Traumeel S. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Traumeel S compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Traumeel S. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shaare Zedek Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: SShaare Zedek Medical Center

Traumeel S

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Mucositis2 trials

Hallux valgus1 trial

Sprain1 trial

Fracture1 trial

Hip Arthroplasty1 trial

Tonsillectomy1 trial

Dexamethasone1 trial

References

Drug Info

Quick Facts

Related News